Human erythropoietin
Recombinant Human Erythropoietin in the Treatment of the Anemia of Prematurity: Results of a Double-Blind, Placebo-Controlled Study
... Recombinant Human Erythropoietin in the Treatment of the Anemia of Prematurity:. Services[r] ...
8
Recombinant Human Erythropoietin in Children with Solid Tumors and Chemotherapy-induced Anemia
... recombinant human erythropoietin (rHuEPO) at a dose of 450 IU/kg subcutaneously once a week for 12 weeks, and the control group (n=28) received no intervention in this ...
7
Myoblast transfer of human erythropoietin gene in a mouse model of renal failure
... recombinant erythropoietin has dramatically improved the quality of life of patients with ...of human erythropoietin ...functional human EPO, increased hematocrit from ...
7
Application of polymeric nanoparticles in oral delivery of recombinant human erythropoietin: A review
... Recombinant Human Erythropoietin drugs are known as erythropoietin stimulating agents which stimulate the bone marrow to produce more red blood cells in the ...recombinant human ...
5
Recombinant Human Erythropoietin Stimulates Erythropoiesis and Reduces Erythrocyte Transfusions in Very Low Birth Weight Preterm Infants
... Erythrocyte Transfusions in Very Low Birth Weight Preterm Infants Recombinant Human Erythropoietin Stimulates Erythropoiesis and Reduces. http://pediatrics.aappublications.org/content/95[r] ...
10
Early Treatment of Premature Infants With Recombinant Human Erythropoietin
... In our study, judgment of efficacy of rhEPO in the treatment of anemia of prematurity requires careful attention because many infants were in an unstable condition, as expressed by the s[r] ...
7
Recombinant Human Erythropoietin Treatment for Chemotherapy-related Anemia in Children
... cisplatin were randomly assigned to either erythro- poietin or nonerythropoietin groups. They compared rHuEPO and placebo, but their study did not include patients who had a non-CDDP-containing regimen. In our study, the ...
6
Original Article Perioperative administration of erythropoietin combined with iron sucrose in gynecological tumor patients: a retrospective study
... recombinant human erythropoietin (rhEPO) combined with iron sucrose on red blood cell (RBC) mobilization and on the rate of blood transfusion in anemic patients undergoing gynecological tumor ...
6
An Approach to Using Recombinant Erythropoietin for Neuroprotection in Very Preterm Infants
... The rationale for our study was that early administration of high-dose recombinant human erythropoietin may reduce perinatal brain injury (intraventricular hemorrhage and periventricular[r] ...
10
Serum erythropoietin levels, breast cancer and breast cancer initiating cells
... serum erythropoietin levels negatively correlated with the number of putative breast CICs in the tumor ...endogenous erythropoietin levels in response to tumor-related anemia as opposed to relatively large ...
13
CLINICAL PRACTICE OF RECOMBINANT HUMAN ERYTHROPOETIN IN CANCER RELATED ANEMIA
... recombinant human Erythropoietin (rHuEPO), an alternative to red blood cell transfusion has become available rHuEPO is now widely used in Cancer patients, as it improves hematocrit, lowers blood transfusion ...
6
Steinsiek, Anna-Lena (2017): Wirkung von Erythropoetin auf Arteriosklerose, arterielles Remodeling und arterielle Thrombose in einem Mausmodell mit Überexpression von humanem Erythropoetin. Dissertation, LMU München: Tierärztliche Fakultät
... recombinant human erythropoietin on platelet production in dialysis. patients.[r] ...
154
Human Recombinant Erythropoietin in Asphyxia Neonatorum: Pilot Trial
... centrations. The HIE-erythropoietin and HIE-control groups included newborns with HIE who fulfilled the following in- clusion criteria: (1) inborn infants at term gestation (38 – 42 weeks), (2) Ap- gar scores of ⱕ ...
10
Nonhematopoietic Erythropoietin Derivatives Prevent Motoneuron Degeneration In Vitro and In Vivo
... of human EPOR), and the sc-679 blocking peptide were ob- tained from Santa Cruz Biotechnology (CA, ...nant human (rh) EPO was obtained from Ortho Biotech (Raritan, NJ, USA); rhCEPO and rhASIALO-EPO were ...
8
Role of endogenous prostaglandin E2 in erythropoietin production and dome formation by human renal carcinoma cells in culture
... Studies were carried out on the role of endogenous prostaglandin E2 PGE2 in erythropoietin Ep production and dome formation in primary monolayer cultures of a human renal carcinoma from [r] ...
11
Allogeneic Blood Transfusion Given Before Radiotherapy Is Associated with the Poor Clinical Outcome in Patients with Cervical Cancer
... temic disease. In our patients, there was higher incidence of normocytic anemia in older patients (5/9 in < 50 vs. 3/4 in 50), suggesting the con- tribution of chronic condition promoting cytokine- mediated process, ...
11
Regulation of erythropoiesis 18 The effect of vincristine and erythropoietin on bone marrow
... THE PERCENTAGE OF ERYTHROID PRECURSORS IN.THE MARROW OF HYPERTRANSFUSED ANIMALS GIVEN ERYTHROPOIETIN EP , VINCRISTINE VG, ERYTHROPOIETIN IMMEDIATELY AFTER VINCRISTINE, VCEP, OR ERYTHRO-P[r] ...
11
Erythropoietin for the Treatment of Subarachnoid Hemorrhage: A Feasible Ingredient for a successful Medical Recipe
... hormone erythropoietin (EPO) has been found to exert neuroprotective action during experimental SAH when its recombinant form (rHuEPO) is administered ...recombinant human EPO in the setting of ...
9
Autocrine stimulation by erythropoietin and autonomous growth of human erythroid leukemic cells in vitro
... Autonomous colony formation is a frequent event in erythroleukemia. In 13 cases of early erythroid leukemias, we investigated whether erythropoietin (Epo) autocrine stimulation was responsible for the growth ...
10
Ion channels in human erythroblasts Modulation by erythropoietin
... in human erythroblasts was ...by erythropoietin, suggesting erythropoietin modulated a voltage-independent ion channel permeable to ...in human erythroblasts. The magnitude of ...
8